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Abstract
Background: Neurogenic inflammation plays a major role in the pathogenesis of inflammatory bowel disease (IBD). We
examined the role of neuropeptide Y (NPY) and neuronal nitric oxide synthase (nNOS) in modulating colitis.
Methods: Colitis was induced by administration of dextran sodium sulphate (3% DSS) or streptomycin pre-treated
Salmonella typhimurium (S.T.) in wild type (WT) and NPY (NPY
2/2) knockout mice. Colitis was assessed by clinical score,
histological score and myeloperoxidase activity. NPY and nNOS expression was assessed by immunostaining. Oxidative
stress was assessed by measuring catalase activity, glutathione and nitrite levels. Colonic motility was assessed by isometric
muscle recording in WT and DSS-treated mice.
Results: DSS/S.T. induced an increase in enteric neuronal NPY and nNOS expression in WT mice. WT mice were more
susceptible to inflammation compared to NPY
2/2 as indicated by higher clinical & histological scores, and myeloperoxidase
(MPO) activity (p,0.01). DSS-WT mice had increased nitrite, decreased glutathione (GSH) levels and increased catalase
activity indicating more oxidative stress. The lower histological scores, MPO and chemokine KC in S.T.-treated nNOS
2/2 and
NPY
2/2/nNOS
2/2 mice supported the finding that loss of NPY-induced nNOS attenuated inflammation. The inflammation
resulted in chronic impairment of colonic motility in DSS-WT mice. NPY –treated rat enteric neurons in vitro exhibited
increased nitrite and TNF-a production.
Conclusions: NPY mediated increase in nNOS is a determinant of oxidative stress and subsequent inflammation. Our study
highlights the role of neuronal NPY and nNOS as mediators of inflammatory processes in IBD.
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Introduction
Recently neural immune regulation has been identified to play a
major role in the pathogenesis of inflammatory bowel disease (IBD)
[1,2,3]. Changes in the enteric nervous system (ENS) observed during
IBD include, modifications in morphology (neuronal hyperplasia and
large internodal fiber tracts), neuromediator content of enteric
neurons and changes in the function of enteric neurons (impaired
release of neuromediators) [4]. These changes in enteric neurons are
likely to play a role in alterations in motility and secretory functions of
the gastrointestinal tract [5]. Neurotrophins such as Nerve Growth
Factor (NGF) increase in inflamed tissues and NGF have been shown
to be increased in patients with Crohn’s disease (CD) and ulcerative
colitis (UC) [6]. The mechanisms by which dysregulated immune
response initiates and perpetuates inflammatory intestinal injury are
not entirely known. There is evidence that gastrointestinal inflam-
mation is related to an imbalance in the function of peptidergic
neurons, including Substance P (SP), Vasoactive Intestinal Peptide
(VIP) and NPY [7,8]. Neuropeptides like SP are up regulated in DSS
model of experimental colitis, and there is increased expression of SP
binding sites in UC and CD [9].
The NPY family of neuropeptides, including NPY, peptide YY
(PYY), and pancreatic polypeptide (PP), has been shown to elicit
diverse biological functions including hypothalamic control of food
intake, anxiety and sedation. These polypeptides are coupled to
heptahelical G-protein coupled receptors. NPY receptor co
localizes with NPY-producing nerve cells and is widely distributed
in the enteric and the central nervous system (CNS).
We have previously demonstrated that neuropeptide Y (NPY)
increases the number of nNOS (neuronal nitric oxide synthase)
containing neurons in vitro and in NPY knock out (NPY
2/2) mice
there is a reduction in nNOS neurons [10]. The nNOS produces
nitric oxide (NO), a major Non-adrenergic Non-cholinergic
(NANC) neurotransmitter, which mediates relaxation responses
of smooth muscles in the gastrointestinal (GI) tract. nNOS has
been identified to play a role in a variety of enteric neuropathies
like Crohn’s disease, ulcerative colitis, Chagas disease, diabetic
gastroparesis, achalasia and pyloric stenosis [11].
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intestinal inflammation are not known. In the present study we
analyzed the role of NPY in modulating inflammation associated
with DSS and Salmonella models of colitis. We hypothesized that an
increase NPY leads to an increase in nNOS neurons, resulting in
increased oxidative stress, thereby aggravating colonic inflamma-
tion. Studies were performed in WT, NPY
2/2, nNOS
2/2 as well as
NPY
2/2/nNOS
2/2 double knock out mice models to understand
the effects of absence of either NPY or nNOS in colonic
inflammation.
Materials and Methods
Reagents and Antibodies
Tyramide signal amplification kit (TSA-Cy-3 and TSA-FITC)-
NEN Life Science Products, Wellesley, MA; dextran sodium
sulfate (DSS, molecular weight, 50000; Lot no 3414 H) - MP
Biomedicals, Aurora, OH; NPY - BACHEM, King of Prussia, PA;
L-NAME -Cayman Chem, Ann Arbor, MI; Omniscript Reverse
Transcription kit -Qiagen, Valencia, CA; NPY primers -IDT, Taq
DNA polymerase and Greiss assay kit -Promega, Madison, WI. All
chemicals not included above were from Sigma, St.Louis, MO.
The real time PCR was performed using Fast SYBRH Green
Master Mix from Applied Biosystems, Foster city, CA. The
antibodies to NPY, nNOS and peripherin (Chemicon Interna-
tional, Temecula, CA), Donkey anti-rabbit biotin and peroxidase-
conjugated streptavidin from Jackson Immuno Research Labora-
tories, Inc, West grove, PA.
Mice
All animal studies were approved by the Emory University
Institutional Animal Care and Use Committee (IACUC). WT
control (Stock No. 002448, 129 S3/SvImJ) NPY
2/2 mice (Stock
No. 004545, strain 129S-Npy
tm1Rpa/J) [12] and nNOS knock out mice
(nNOS
2/2) (Stock No 002633, strain B6; 129 S4-Nos1
tm1Plh/J) were
obtained from The Jackson Laboratory, Bar Harbor, ME. In nNOS
knock out mice (nNOS
2/2) a neomycin cassette replaced exon 1 which
encodes the initiation site and amino acids 1–159 of the neuronal
nitric oxide synthase (nNOS 1) protein.
Generation of NPY
2/2/nNOS
2/2 Double knock out mice
NPY
2/2 mice and nNOS
2/2 mice were obtained from The
Jackson Laboratory were crossed in our animal facility to obtain
the F1 heterozygotes, which were then crossed for obtaining the
double knockouts. The corresponding double positive mice from
breeding were used as the WT control in the experiments. The
genotype of all the mice were verified prior to experiments by RT-
PCR of mouse tail using the RED-Amp Kit (Sigma).
Induction of DSS colitis
Colitis was induced in eight week old WT and NPY
2/2age and
sex matched male and female WT and NPY
2/2 littermates by oral
administration of 3% (w/v) DSS in tap water ad libitum for 6 days.
Age-matched male and female WT and NPY
2/2 mice receiving
tap water served as controls. Mice were evaluated for clinical
symptoms of colitis. The animals were sacrificed on day 6 and
tissues were processed for analyses.
Figure 1. DSS induces NPY expression in the enteric ganglia. (A) RNA was isolated from WT and NPY
2/2 mice given water or 3% DSS and
amplified for NPY and 18S rRNA (loading control). The increase in NPY mRNA expression as assessed by real-time PCR is graphically represented as
fold change compared to control. Each bar represents mean6S.E; n=4, Significant difference from all other groups represented as * p,0.05, **
p,0.01 (B) Confocal images of single enteric ganglion from control and DSS- treated WT mice assessed for peripherin (green) and NPY (red) are
shown. Magnification 40X, Scale bar 5 mm.
doi:10.1371/journal.pone.0003304.g001
NPY and Colitis
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gastroenteritis
Gut-restricted S. typhimurium (S.T.), (strain SL3201) infection was
induced after pre-treatment with streptomycin according to Barthel
et al [13] in eight week old WT , NPY
2/2, nNOS
2/2 and NPY
2/2/
nNOS
2/2 double knock out mice. After 48 hrs post infection, cecum
and colonsampleswerecollected.Grosschange incecalmorphology
in control and S.T infected group was evaluated.
Clinical Score
Body weight, stool consistency, presence of occult or gross blood
in feces by guaiac test (Hemoccult Sensa, Beckman Coulter,
Fullerson, CA) were assessed daily for each animal in DSS colitis
and clinical scoring done as per Cooper et al [14]. Mice were
sacrificed by carbon dioxide on day 6. The length of colon was
also measured.
Histological score
Distal colon sections were stained with hematoxylin and eosin
(H/E) [15] and damage was scored as per Cooper et al [14].
Myeloperoxidase Assay
Distal colons from DSS treated mice (day 6) and cecum from
S.T. -treated mice (48 h) were snap-frozen in liquid nitrogen, and
myeloperoxidase activity was measured [16] and expressed per mg
of protein.
KC Assay
WT, NOS
2/2 and NPY
2/2/NOS
2/2 mice were bled at
48 hours after S.T. infection through the retro-orbital plexus.
The serum was isolated by centrifugation and levels of murine
neutrophil chemoattractant KC assayed using the mouse Duoset
ELISA kits [17] (R&D Systems).
Reverse Transcription and Real-Time Polymerase Chain
Reaction
Total RNA was isolated from distal colon (RNeasy Mini Kit ,
Qiagen) from WT/NPY
2/2 mice treated with water or DSS or
S.T. The reaction mixtures were then set up with cDNA and
primers for NPY [18,19]. The amplification products were
visualized on a 1.5% agarose gel. NPY expression was normalized
Figure 2. Lack of NPY inhibits DSS-induced inflammation. Mice were randomized into 4 groups: WT water or DSS (3%) and NPY
2/2 water or
3% DSS and sacrificed on day 6. (A) Representative hematoxylin eosin (H/E) stained sections of colon from each group are shown. Arrows represent
neutrophil infiltration and crypt damage. Magnification 10X and 40X. Disease severity was assessed as described in the Materials and Methods and
expressed in terms of (B) Histological score (C) Clinical score and (D) Myeloperoxidase activity. Each bar represents mean6S.E; n=4, Significant
difference from all other groups represented as * p,0.05, ** p,0.01.
doi:10.1371/journal.pone.0003304.g002
NPY and Colitis
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MyiQ Optical System software 2.0.
Immunofluorescence Studies
Distal colon from individual WT and NPY
2/2 mice treated with
water or DSS were processed and stained with anti-NPY or anti-
nNOS antibodies (1:1000) and Peripherin was used as a neuronal
marker (1:5000), as described previously [10].
Confocal Microscopy
Zeiss LSM410 microscope was used and green fluorescence was
excited at 488 nm and detected with a 515–540 nm band-pass
filter. Red fluorescence was excited at 543 nm and detected with a
570 nm long-pass filter. The intensity of staining in the ganglion
was assessed using the Metamorph Imaging system, Molecular
Devices, Sunnyvale, CA. At least 8 ganglia were measured to get
the average nNOS intensity. The intensity assessment was done by
a researcher blinded to the treatment groups.
Catalase Activity
The distal colon segments from control, DSS- WT and DSS-
NPY
2/2 mice were collected and catalase activity was determined
by spectrophotometric method [15,20].
Nitrite estimation in the colon
Distal colon collected from control and DSS –treated mice (WT
and NPY
2/2) was homogenized in phosphate buffered saline and
supernatant was used for the assay using Greiss assay kit.
Glutathione assay
Colonic tissue (50 mg) was processed for reduced glutathione
(GSH) analysis by HPLC [21].
Nitric oxide and TNF- a production from neuronal
cultures
Enteric neurons isolated from E14 rat embryos as previously
described [19] were exposed to NPY (1 mM) for 24 h. The
Figure 3. S.T. induces NPY expression in the enteric ganglia. (A)RNA was isolated from WT and NPY
2/2 mice given water or S.T. (48 hrs), and
amplified for NPY and 18 S RNA (loading control). The increase in NPY mRNA expression as assessed by real-time PCR is graphically represented as
fold change compared to control. Each bar represents mean6S.E; n=4, Significant difference from all other groups represented as * p,0.05, **
p,0.01 (B) Confocal images of single enteric ganglion from control and S.T.- treated WT mice assessed for peripherin (green) and NPY (red) are
shown. Magnification 40X, Scale bar 5 mm.
doi:10.1371/journal.pone.0003304.g003
NPY and Colitis
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assay) and TNF- a (ELISA kit BioSource, Invitrogen, CA).
Assessment of colonic motility by Isometric muscle
recording with electrical field stimulation (EFS)
The relaxation responses from the longitudinal muscle strips
containing the myenteric plexi from the proximal colon of WT,
NPY
2/2, NOS
2/2 and NPY
2/2/nNOS
2/2 mice were assessed as
described earlier [11]. The responses from DSS- treated WT mice
at 0, 2 and 5 weeks after withdrawal of DSS were also determined.
For quantitative determination of responses, at least 3 animals
were used in each group and the average response obtained.
Statistical analysis
Data were analyzed by t-test or One-way ANOVA with Tukey’s
post test, using GraphPad Prism version 3.00 for Windows,
GraphPad Software, San- Diego California, USA. Results were
considered significant at P,0.05.
Results
NPY expression is up regulated in enteric neurons during
experimental colitis in WT mice
Reverse-transcription PCR indicated an increase in NPY
expression after DSS and Salmonella exposure (Figure 1A and
Figure 3A). Further experiments by Real-time PCR indicated a
significant increase in NPY mRNA (25.7762.67, p,0.05) after
two days of DSS exposure in WT mice (graphically represented in
Figure 1A as fold change compared to control), and also after S.T.
treatment (5.9660.7, p,0.01, Figure 3A, graphically represented
as fold change compared to control). Immunostaining revealed
increased NPY expression in the enteric ganglia of DSS (Figure 1B)
Figure 4. NPY
2/2 mice are resistant to S.T.-induced colitis. (A) Representative sections of hematoxylin eosin (H/E) stained sections of colon
from WT and NPY
2/2 mice given water/S.T.. Arrows represent neutrophil infiltration and crypt damage. Magnification 10X and 40X. (B) Morphology
of cecum (C) Percent cecum shrinkage in WT mice and NPY
2/2 mice. Disease severity was assessed as described in the Materials and Methods section
in terms of (D) Histological score and (E) Myeloperoxidase activity. Each bar represents mean6S.E; n=4, Significant difference from all other groups
represented as *** p,0.001.
doi:10.1371/journal.pone.0003304.g004
NPY and Colitis
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both DSS and S.T. treatment induced an increase in neuronal
NPY expression.
NPY
2/2 mice are resistant to the development of Dextran
sodium sulfate and Salmonella- induced colitis
Since DSS/S.T. induced NPY expression in the enteric ganglia,
we next assessed the effects of lack of NPY on inflammation. The
NPY
2/2 mice were resistant to DSS colitis as assessed by histological
score, clinical score and blood in stool (Figure 2, B–D). DSS-WT
mice had a significant (10.9161.5%, p,0.05) reduction in body
weight and increased blood loss as compared with controls. In
contrast NPY
2/2 mice exhibited less inflammation with an overall
clinical score of 460.7 compared to a score of 960.5 in DSS-WT
mice (p,0.01, Figure 2C). Reduction of colon length, which is used
as a parameter of inflammation, correlated with the clinical scores
[22]. The colon length of DSS-WT mice was significantly less
(5.060.08, p,0.05) as compared to the controls(6.060.2). However
in NPY
2/2 group there was no significant differences in colon length
between DSS and control mice.
DSS-induced colitis is featured by colonic inflammation mani-
fested by crypt damage, mucosal destruction, epithelial erosions and
infiltration of inflammatory cells into the mucosa. Tissues from DSS
treated WT and NPY
2/2 mice were examined histologically and
compared with the controls. The histological data supported the
observations based on clinical analysis and confirmed the protective
role of NPY deletion towards the development of colitis (Figure 2 A).
Distal colonic segments collected from DSS (Figure 2A) and
Salmonella treated (Figure 4A) WT mice showed visible signs of
colonic inflammation and tissue damage. There was extensive crypt
damage, epithelial erosion, ulcer formation and infiltration of
neutrophils into the lamina propria and muscularis of colonic
sections. In contrast histological analysis of colonic sections from
NPY
2/2 mice showed significantly reduced histological inflamma-
tion, and there was reduced mucosal damage and less infiltration.
Thehistologicalscore(Figure2B)onDSStreatmentwassignificantly
lower in NPY
2/2 mice (1.660.55) compared to that in WT mice
(6.6960.69). The histological score in S.T. treated WT mice was
significantly higher (1060.5) when compared to the NPY
2/2 mice
(560.8) indicating a better resistance (Figure 4D) associated with
deletion of NPY. The S.T. infection is characterized by shrinkage of
cecum (Figure 4B) and we found that WT mice suffered from 43.8%
loss of cecum weight as compared to 2.4% in NPY
2/2 mice
(Figure 4C).
Neutrophil infiltration into the injured tissue is a characteristic
feature of colitis. To validate the histological findings we assessed
the myeloperoxidase activity (MPO), an index of neutrophil
infiltration, in the colon (DSS treated) and cecum (S.T. treated) of
WT and NPY
2/2 mice. Compared to WT control, the mice
receiving DSS had significantly higher (p,0.01) MPO activity
(Figure 2D). In contrast, MPO activity in DSS-treated NPY
2/2
mice was 50% less than DSS-WT mice. S.T. infection also resulted
in higher MPO activity in WT mice as compared to the NPY
2/2
mice (Figure 4E). These data indicate that deletion of NPY
attenuated clinical as well as histological characteristics associated
with DSS and salmonella-induced colitis.
Figure 5. Neuronal NOS (nNOS) expression and nitrite levels are increased in DSS-treated mice. (A) Distal colons of WT and NPY
2/2 mice
treated with water and DSS (3%), were fixed in formalin and processed for nNOS immunostaining as described in methods section, Magnification 20X,
Scale bar 20 mm. (B) Graphical representation of relative intensity of nNOS staining as determined by Metamorph program (C) Nitrite levels, an index
of nitric oxide production, were measured by Greiss assay as described in Materials and methods section. Each bar represents mean6S.E; n=4,
Significant difference from all other groups represented as * p,0.05, **p,0.01.
doi:10.1371/journal.pone.0003304.g005
NPY and Colitis
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We have previously demonstrated that NPY
2/2 mice have a
reduced number of nNOS enteric neurons [10]. To assess if DSS
induced NPY can modulate nNOS, we assessed the expression of
nNOS in enteric ganglia by immunofluorescence. DSS induced a
significant increase in nNOS (Figure 5A) expression in the enteric
ganglia of WT mice as compared to NPY
2/2 mice as graphically
represented in Figure 5B. This increased expression of nNOS in
WT mice resulted in higher levels of nitric oxide production as
revealed from higher nitrite levels (p,0.05) as compared to NPY
2/
2 mice (Figure 5C). The NPY
2/2 mice lack NPY and hence have
less nNOS, and this can contribute to decreased nitric oxide
production and nitrite levels in response to DSS.
NPY
2/2 mice have decreased oxidative stress
We next examined if the DSS-induced NPY expression and
subsequent nNOS expression resulted in increased oxidative stress.
The catalase activity, an index of peroxide stress, was significantly
higher (p,0.05) in colonic tissues of DSS- WT mice when
compared to NPY
2/2 mice (Figure 6A). The levels of reduced
glutathione (GSH) was significantly less in WT mice exposed to
DSS, further pointing to increased oxidative stress, where as GSH
levels were higher in DSS-NPY
2/2 mice (Figure 6B).
nNOS
2/2 and NPY
2/2 nNOS
2/2 mice are resistant to the
development of Salmonella- induced colitis
In order to validate the observation that NPY mediated increase
in nNOS is responsible for increased oxidative stress and sub-
sequent damage in colitis; we induced S.T. colitis in nNOS
2/2 and
NPY
2/2/nNOS
2/2 mice. These results are represented in Figure 7
(A–E). Both nNOS
2/2 and NPY
2/2/nNOS
2/2 mice exhibited less
inflammation as evident from histological damage (Figure 7A), less
cecum shrinkage (Figure 7B), decreased histological score
(Figure 7C) and MPO activity (Figure 7D). KC is a chemokine
in mice that is capable of recruiting and activating neutrophils. It is
the human homolog of IL-8 in mice, and hence is a useful marker
to assess inflammation. We found that KC levels were much less in
nNOS
2/2 and NPY
2/2/nNOS
2/2 mice (Figure 7E) as compared
to the respective wild type controls. This suggested that NPY-
mediated damage in colitis is through nNOS.
Colonic relaxation was chronically impaired in WT mice
after DSS treatment. Among the various inhibitory
neurotransmitters, neuronal nitric oxide (NO) generated by
nNOS contributes mainly to NANC relaxation. The NANC
relaxation in the longitudinal muscle strips (containing the
myenteric plexus) from the proximal colon of WT, NPY
2/2,
nNOS
2/2 and NPY
2/2/NOS
2/2 control mice is represented in
Figure 8A. The WT control mice that harbor both NPY and
nNOS exhibited maximum relaxation response (54.666.26%). As
previously demonstrated [10], NPY
2/2 mice have reduced
relaxation responses (18.7864.05%) due to a reduction in
nNOS neurons. We found that nNOS
2/2 mice (in spite of
having NPY) also exhibited decreased relaxation response
(25.2764.63%). There was only minimal relaxation in the
NPY
2/2 NOS
2/2 double knock out mice. This indicates that
majority of relaxation response is mediated by NPY and nNOS.
This data confirmed the role of NPY and nNOS as the major
determinants of NO- mediated relaxation. In the DSS-treated WT
mice, inflammation results in destruction of neurons and loss of
relaxation responses. The impairment in relaxation was persistent
even 5 weeks after DSS treatment indicating more inflammation
and damage to neurons (Figure 8B).
NPY-treated enteric neurons exhibit increased nitrite and
TNF-a production
We have previously shown that NPY can increase nNOS neurons
in vitro [10]. In the present study we observed that NPY can induce
nitric oxide production and TNF-a release from enteric neuronal
cultures. There was increased nitric oxide production as seen from
significantly higher nitrite (0.58560.002 mM, p,0.001) in NPY-
treated enteric neuronal cultures compared to untreated controls
(Figure 9 A). Similarly, TNF-a release (pg/mL of media) was also
significantly higher from NPY-treated neuronal cultures (40.1267.7)
compared to untreated controls (19.5962.41) (Figure 9 B). These
findings indicate that NPY contributes to increased nitrosative stress
and enhances release of inflammatory mediators like TNF-a.T h u s ,
NPY-containing neurons can make a significant contribution during
an inflammatory process.
Discussion
The enteric nervous system has been shown to play an important
role in the pathophysiology of inflammatory bowel disease [23]. The
present study highlights the role of enteric neurons as modulators of
inflammatory processes in IBD. NPY is produced by enteric neurons
as well as the central nervous system (CNS). Of the total neurons in
the mice colon, NPY containing neurons represent 50% of the total
neurons in myenteric plexi and less than 5% neurons in the sub
Figure 6. Oxidative stress is significantly reduced in NPY
2/2
mice. Distal colons were snap-frozen in liquid nitrogen for assessment
of oxidative stress. (A) Catalase activity was measured spectrophoto-
metrically as an index of oxidative stress as described in Materials and
methods section, and (B) Colonic GSH levels in vehicle (water-treated)
and DSS-treated WT and NPY
2/2 mice as measured by HPLC. Each bar
represents mean6S.E; n=4, Significant difference with respect to other
groups represented as * p,0.05.
doi:10.1371/journal.pone.0003304.g006
NPY and Colitis
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described in inflammation. Ourstudydemonstratesincreased colonic
expression of NPY in DSS and S.T. colitis. Thus, NPY is an inducible
gene in enteric neurons which can promote inflammation.
To investigate the role and involvement of NPY in the
development of chemical and infectious colitis, mice with targeted
disruption of NPY gene, and WT mice were evaluated for clinical
and histopathologic manifestations of colitis. DSS-induced colitis is
a well established preclinical model to understand the pathophys-
iology of intestinal inflammation as it bears a close resemblance to
human colitis [25]. Our study demonstrates that WT mice
exposed to DSS shows significant weight loss, increased fecal blood
and neutrophil infiltration, crypt damage and epithelial erosions.
Unlike WT mice, NPY
2/2 mice exhibited significantly lower
clinical and histological manifestations in response to DSS. Similar
histological findings indicating more inflammation was also noted
in S.T -treated WT mice, as characterized by cecum shrinkage,
crypt damage and ulceration when compared to NPY
2/2 mice.
Polymorphonuclear leukocyte migration across the epithelium is
considered as a key feature in active inflammatory diseases like
chronic ulcerative colitis (CUC) and IBD. There was significant
accumulation of neutrophils in the colonic mucosa of WT mice,
however there was only minimal inflammatory infiltrates in knock
out mice, suggesting the role of NPY in neutrophil recruitment. It
has been demonstrated that activation of sympathetic neuro
transmitters like NPY and epinephrine mobilizes blood leucocytes
[26]. NPY has also been demonstrated to prime polymorphonu-
clear (PMN) oxidative metabolism [27]. Similarly, we also noted
increased MPO activity in WT mice treated with DSS/S.T. as
compared to the NPY
2/2 counterparts.
Our studies demonstrate a role for the neuronal NOS, along with
NPY, in the pathogenesis of colitis. Our laboratory has previously
shown that NPY can increase nNOS neurons in vitro [10], and that
NPY
2/2 mice have reduced number of nNOS neurons. In the
current study we observed that DSS induces NPY expression and up
regulation of nNOS. The role of nitric oxide synthases and nitric
Figure 7. nNOS
2/2 and NPY
2/2/nNOS
2/2 mice resist S.T. colitis. Distal colon was isolated from mice given water or S.T. (48 hrs) (A)
Representative hematoxylin eosin stained sections of colon from each group are shown. Magnification 40X, Scale bar 100 mm. Disease severity was
assessed as described in the Materials and Methods section in terms of (B) Morphology of cecum (C) Histological score (D) MPO activity and (E) KC
levels in the serum at 48 hrs of S.T. infection. Each bar represents mean6S.E, n=4, Significant difference with respect to other groups represented as
*** p,0.001.
doi:10.1371/journal.pone.0003304.g007
NPY and Colitis
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have shown that NOS inhibitors like L-NAME has been able to
attenuate [28,29] or exacerbate [30] TNBS-induced colitis. We
observed a significant upregulation of nNOS (by immunostaining)
on the enteric ganglia in WT mice compared to NPY
2/2 mice. We
believe that the increased nitrite noted in colitis is due to the
increased nNOS. Our in vitro studies now demonstrate that enteric
neuronal cultures treated with NPY had increased nitrite levels,
which indicates increased nitric oxide production.
Colonic oxidative stress is a hallmark of IBD and colonic nitrite
levels serve as a sensitive marker of disease activity in colitis [31] .
It has been demonstrated that increase in nitric oxide in colon in
ulcerative colitis is from myenteric neurons and not epithelium or
endothelium [32]. There was further evidence of increased
oxidative stress in the DSS-treated WT mice as seen by the
significant increase in catalase activity and reduced GSH levels.
Inflammatory cells may also contribute to elevated nitrite levels
and catalase activity due to increased neutrophil infiltration (as
evidenced by increased myeloperoxidase activity) that occurs in
presence of NPY.
In order to validate the observation that NPY-mediated increase
in nNOS is responsible for increased oxidative stress and
subsequent damage in colitis, we used S.T. model to study the
effect of the absence of nNOS as well as absence of both NPY and
NOS in inflammation. We observed that inflammation was
significantly reduced in nNOS
2/2 mice as well as NPY
2/2/
nNOS
2/2double knockouts. The presence of NPY in the nNOS
2/2
could not help restore the S.T. induced inflammatory response.
Isometric muscle recording data support reduced relaxation
response in NPY
2/2, nNOS
2/2 and NPY
2/2/nNOS
2/2 mice.
This supports our hypothesis that NPY-nNOS induced nitric
oxide is a major determinant of oxidative stress -induced damage
in colitis.
It is known that post ganglionic sympathetic nerve fibers
terminate in lymphoid organs and secrete NPY which regulates
multiple physiological processes in the body [33]. NPY can also
activate macrophages and immune cells, Th1 responses, and
stimulate the production of various cytokines [34,35]. TNF –a
production from the spinal cord neurons has been demonstrated in
inflammatory central nervous system diseases like experimental
allergic encephalomyelitis [36]. Our study has demonstrated that
NPY has the capacity to stimulate TNF-a production from enteric
neurons in culture. This observation highlights the fact that enteric
neurons are additional sources of cytokines during inflammatory
Figure 8. Colonic motility in WT, NPY
2/2, nNOS
2/2 and NPY
2/2/nNOS
2/2 mice. EFS-induced relaxation of longitudinal muscle strips was
assessed as described in Materials & Methods. Transmural EFS-induced relaxation (24 V, 8 Hz, 5 milliseconds, 60 seconds) of the proximal colon was
assessed in mice colons pre-contracted with 5-HT in presence of atropine and guanethidine. Representative tracings of NANC relaxation in (A) WT,
NPY
2/2, nNOS
2/2 and NPY
2/2/nNOS
2/2 vehicle mice, and (B) in DSS-treated WT mice at 2 and 5 weeks after DSS treatment are presented and also
graphically represented. The y axis represents force in mN, and the x axis represents time with arrows representing 5-HT, EFS-on and EFS-off
respectively. Percentage relaxation was calculated by determining the difference between the maximal force generated at baseline and the minimum
force following electrical stimulation and expressing this as a percentage of the force generated at baseline. Bar graphs represent the percent
relaxation responses with respect to 5-HT-induced contraction. Each bar represents mean6S.E; n=3 for each group, Significant difference from all
other groups represented as ***p,0.001.
doi:10.1371/journal.pone.0003304.g008
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contribution during an inflammatory process.
The increased severity of inflammation in the WT mice was also
noted by functional impairment of neuronally-mediated muscle
contractions and relaxations even after 5 weeks of DSS
withdrawal. This indicates that neuronal damage secondary to
inflammation can lead to long term gastrointestinal motility
problems.
In summary, our study demonstrates that NPY from enteric
neurons is up regulated during colitis and it can regulate the
expression of nitric oxide synthase and subsequent nitric oxide
production. Possible mechanisms of NPY-mediated inflammation
are via increased oxidative stress and cytokine release. The
inflammation in turn results in chronic impairment of GI motility.
Taken together our data reveal that enteric neurons producing
NPY play an important role in modulating inflammation in colitis.
NPY-dependent mechanisms participate in the adaptive changes
of neurons in response to injury/inflammation. We show that the
enteric nervous system not only participates in the pathophysiol-
ogy of inflammation, but also is affected as a consequence of
inflammation. Persistence of the changes in enteric neurons in the
recovery phase can explain some of the motility disturbances seen
in patients with inflammatory bowel disease even in the absence of
inflammation. Hence targeting this neuropeptide may have a
therapeutic value in managing inflammatory bowel disease.
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